| Prasugrel versus clopidogrel in patients with acute coronary syndromes SD Wiviott, E Braunwald, CH McCabe, G Montalescot, W Ruzyllo, ... New England Journal of Medicine 357 (20), 2001-2015, 2007 | 8167 | 2007 |
| 2018 ESC/EACTS Guidelines on myocardial revascularization FJ Neumann, M Sousa-Uva, A Ahlsson, F Alfonso, AP Banning, ... European heart journal 40 (2), 87-165, 2019 | 7703 | 2019 |
| 2014 ESC/EACTS Guidelines on myocardial revascularization S Windecker, P Kolh, F Alfonso, JP Collet, J Cremer, V Falk, G Filippatos, ... Kardiologia Polska (Polish Heart Journal) 72 (12), 1253-1379, 2014 | 6785* | 2014 |
| 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Task Force Members, G Montalescot, U Sechtem, S Achenbach, ... European heart journal 34 (38), 2949-3003, 2013 | 5426 | 2013 |
| ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ... European heart journal 32 (23), 2999-3054, 2011 | 4988 | 2011 |
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3849 | 2006 |
| 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary … M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... European heart journal 39 (3), 213-260, 2018 | 3590* | 2018 |
| Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ... New England Journal of Medicine 352 (12), 1179-1189, 2005 | 2917 | 2005 |
| Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction GW Stone, CL Grines, DA Cox, E Garcia, JE Tcheng, JJ Griffin, ... New England Journal of Medicine 346 (13), 957-966, 2002 | 1807 | 2002 |
| Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction G Montalescot, P Barragan, O Wittenberg, P Ecollan, S Elhadad, P Villain, ... New England Journal of Medicine 344 (25), 1895-1903, 2001 | 1555 | 2001 |
| Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ... Jama 304 (16), 1821-1830, 2010 | 1395 | 2010 |
| Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised … G Montalescot, SD Wiviott, E Braunwald, SA Murphy, CM Gibson, ... The Lancet 373 (9665), 723-731, 2009 | 1387 | 2009 |
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1354 | 2010 |
| Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study JP Collet, JS Hulot, A Pena, E Villard, JB Esteve, J Silvain, L Payot, ... The Lancet 373 (9660), 309-317, 2009 | 1248 | 2009 |
| Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) M Moscucci, KAA Fox, CP Cannon, W Klein, J López-Sendón, ... European heart journal 24 (20), 1815-1823, 2003 | 1160 | 2003 |
| Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes … SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly, CD Joyner, CB Granger, ... The Lancet 376 (9748), 1233-1243, 2010 | 1114 | 2010 |
| Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel … SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ... Circulation 116 (25), 2923-2932, 2007 | 1107 | 2007 |
| Bedside monitoring to adjust antiplatelet therapy for coronary stenting JP Collet, T Cuisset, G Rangé, G Cayla, S Elhadad, C Pouillot, P Henry, ... New England Journal of Medicine 367 (22), 2100-2109, 2012 | 1057 | 2012 |
| Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial DL Bhatt, MD Flather, W Hacke, PB Berger, HR Black, WE Boden, ... Journal of the American College of Cardiology 49 (19), 1982-1988, 2007 | 1025 | 2007 |
| PCI strategies in patients with acute myocardial infarction and cardiogenic shock H Thiele, I Akin, M Sandri, G Fuernau, S de Waha, R Meyer-Saraei, ... New England Journal of Medicine 377 (25), 2419-2432, 2017 | 990 | 2017 |
